Post-Stroke Inflammation and the Potential Efficacy of Novel Stem Cell Therapies: Focus on Amnion Epithelial Cells
Ischemic stroke is a debilitating disease for which there are currently no effective treatments besides the clot-buster, tissue plasminogen activator, which is administered to less than 10 % of patients due to a limited (4.5 h) time window of efficacy. Thus, there is an urgent need for novel therap...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2013-01-01
|
| Series: | Frontiers in Cellular Neuroscience |
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/Journal/10.3389/fncel.2012.00066/full |